Vericel (VCEL) Tops Q4 EPS by 8c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. LRCX
6. LVS
7. CSX
8. SAP
9. QGEN
10. ELV

Go back to Vericel (VCEL) Tops Q4 EPS by 8c

Vericel Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Full-Year 2023 Financial Guidance

February 23, 2023 7:55 AM EST

Record Fourth Quarter Total Revenue of $52.7 Million and 31% Net Income Growth

Full-Year 2022 Total Revenue of $164.4 Million, with MACI Revenue of $132 Million

Full-Year 2023 Total Revenue Guidance of $180 to $188 Million, with MACI Revenue of $152 to $156 Million

Conference Call Today at 8:30am Eastern Time

CAMBRIDGE, Mass., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today reported financial results and business highlights for the fourth quarter and year... More